# METHYLPREDNISOLONE SODIUM SUCCINATE
> **ANDA212396** · Abbreviated New Drug Application (Generic) · Sponsor: TIANJIN KINGYORK · Approved 2021-04-20
## Drug
- **FDA Application Number:** ANDA212396
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** METHYLPREDNISOLONE SODIUM SUCCINATE
- **Generic name:** METHYLPREDNISOLONE SODIUM SUCCINATE
- **Active ingredients:** METHYLPREDNISOLONE SODIUM SUCCINATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** TIANJIN KINGYORK
- **Manufacturer:** Dr. Reddy's Laboratories Inc
- **First approval:** 2021-04-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212396)
---
*AI Analytics · CC0 1.0*